Real-World Quantitative Insights into the Treatment Experience of Patients with Cancer in the USA with Subcutaneous Versus Intravenous Drug Delivery.

ABSTRACT:

Introduction

While oncology treatments have traditionally been delivered through the intravenous (IV) route of administration (ROA), subcutaneous (SC) alternatives have become increasingly available. Research comparing real-world patient experiences with these ROAs in the USA has been limited. This study aimed to quantify and compare preferences, satisfaction, and daily life impact between SC and IV delivery for patients with cancer in the USA experienced with both ROAs in a real-world setting.

Methods

Patients with cancer in the USA experienced with both SC and IV delivery were eligible to complete a 45-question web-based survey if they were at least 18 years of age, had a confirmed self-reported cancer diagnosis, and received both SC and IV treatment for the same condition

SUBMITTER: Epstein R 

PROVIDER: S-EPMC12379195 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature